Amarantus Bioscience Holdings Inc (AMBS)

[tsuguy]

I think share price valuation discussion should be conveyed in market cap valuation. It makes more sense, and is less confusing to general traders on this forum. Then after transfer occurs share valuation will be easily calculated. I think many people are hung up on share price and less on market cap, which as you know is basis for SP. Likely due to lack of knowledge, but that is fine because everyone can learn.

Point being, I think transfer to NASDAQ increases our total valuation firmly to $150 million alone. Once diagnostic division spinoff is announced we should see an additional $150 million valuation. Both combined should value holding company in excess of $300 million.

So in short term, our share valuation should be 3 times its current value once up list occurs and 6 times current value after diagnostic spinoff.

Any additional positive news will only add to market cap value. Investment ownership will be the wildcard once we get up listed. Should see a lot of interest finally payoff from these investment conferences. Great timing, IMO.

Everyone will want to own a piece of action with so many wild cards in our deck.